Stille AB
Research Stille AB (STIL) on Bullrun: valuation model: 2.5% overvalued, market cap SEK 2.06B, P/E 28.4. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSTIL
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencySEK
- Valuation signal2.5% overvalued
- Market capSEK 2.06B
- P/E28.4
- Financial periodQ2 2026
- RevenueSEK 186.87M
- Net incomeSEK 20.56M
- Free cash flowSEK 15.90M
- Gross margin48.4%
Valuation Snapshot
Bullrun's latest valuation model marks Stille AB as 2.5% overvalued; latest market cap is SEK 2.06B; P/E is 28.4.
Peer valuation comparison
Latest P/E is 28.38x versus a Healthcare sector median of 24.46x (16.0% above).
Latest P/E is 28.38x versus a Sweden median of 18.57x (52.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 567.63M | SEK 55.70M | n/a | 50.7% | n/a | SEK 118.66M | SEK 123.26M | SEK 708.71M |
| FY2024 | SEK 571.40M | SEK 60.55M | n/a | 52.5% | n/a | SEK 158.49M | SEK 63.09M | SEK 699.41M |
| FY2023 | SEK 294.90M | SEK 26.66M | n/a | 44.8% | n/a | SEK 241.45M | n/a | n/a |
| FY2022 | SEK 246.36M | SEK 27.33M | n/a | 45.3% | n/a | SEK 36.68M | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | SEK 2.06B | 28.4 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 SEK.
About Stille AB
Stille AB develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Stille AB overvalued or undervalued?
Bullrun's valuation model currently marks Stille AB as 2.5% overvalued.
What is Stille AB's market cap?
Stille AB's market capitalization is SEK 2.06B.
What is Stille AB's P/E ratio?
Stille AB's price-to-earnings (P/E) ratio is 28.4.
What does Stille AB do?
Stille AB develops, manufactures, and distributes medtech products in Sweden, Germany, the United Kingdom, Switzerland, North America, the United States, and internationally. It operates through the Surgical Instruments and Surgical Tables segments.